Clinical Trials Browser

Phase 2 × Thymalfasin × Tumor-Agnostic × Clear all

NCT05790447 2023-03-30

Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors

Phase 2 Unknown

Neoplasms